WATCH: Defensor, Marcoleta lead ivermectin distribution in Quezon City | Inquirer News

WATCH: Defensor, Marcoleta lead ivermectin distribution in Quezon City

/ 03:21 PM April 29, 2021

MANILA, Philippines – Anakalusugan Partylist Rep. Mike Defensor and Deputy Speaker Rodante Marcoleta led the distribution of the antiparasitic drug ivermectin at the barangay hall of Barangay (village) Matandang Balara in Quezon City Thursday.

Radyo Inquirer interviewed the two lawmakers, Dr. Iggy Agbayani, president of the Concerned Doctors and Citizens of the Philippines, and one of the recipients of the antiparasitic drug.

Article continues after this advertisement

Defensor said doctors have given the drug’s recipients prescriptions and that those who received the drug gave their “informed consent” and voluntarily went to the barangay hall to get their free ivermectin pack.

FEATURED STORIES

Each recipient received 10 pieces of ivermectin capsules or the equivalent of one pack.

Earlier, the Department of Health reminded the public that only hospitals that were granted special permits could give ivermectin to COVID-19 patients.

Article continues after this advertisement

RELATED STORIES

Article continues after this advertisement

DOH insists ivermectin only for hospital use; 2 lawmakers defiant

FDA: 5 hospitals granted special permit to treat COVID-19 patients with ivermectin

‘I will fight them in court’: Defensor says if FDA stops ivermectin distribution

/MUF
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Ivermectin, Mike Defensor, Quezon City

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.